Key result
CHIP links to 261 methylation sites tied to cardiovascular traits and mortality.
Why the study?
Does clonal hematopoiesis of indeterminate potential (CHIP) alter epigenome-wide DNA methylation associated with cardiovascular traits and all-cause mortality?
Meta-Analysis (n=8,196)
Yes
Does clonal hematopoiesis of indeterminate potential (CHIP) alter epigenome-wide DNA methylation associated with cardiovascular traits and all-cause mortality?
Answers are grounded in this paper and cite their sources.
CHIP is associated with specific epigenome-wide DNA methylation changes that are causally linked to cardiovascular traits and all-cause mortality, providing insight into the molecular mechanisms of CHIP-related cardiovascular risk.
With age, hematopoietic stem cells can acquire somatic mutations in leukemogenic genes that confer a proliferative advantage in a phenomenon termed CHIP. How these mutations result in increased risk for numerous age-related diseases remains poorly understood. We conduct a multiracial meta-analysis of EWAS of CHIP in the Framingham Heart Study, Jackson Heart Study, Cardiovascular Health Study, and Atherosclerosis Risk in Communities cohorts (N = 8196) to elucidate the molecular mechanisms underlying CHIP and illuminate how these changes influence cardiovascular disease risk. We functionally validate the EWAS findings using human hematopoietic stem cell models of CHIP. We then use expression quantitative trait methylation analysis to identify transcriptomic changes associated with CHIP-associated CpGs. Causal inference analyses reveal 261 CHIP-associated CpGs associated with cardiovascular traits and all-cause mortality (FDR adjusted p-value < 0.05). Taken together, our study reports the epigenetic changes impacted by CHIP and their associations with age-related disease outcomes.
No takes yet. Share an insight, caveat, or question.
Kirmani et al. (2025) conducted a meta-analysis in Clonal hematopoiesis of indeterminate potential (CHIP) (n=8,196). Clonal hematopoiesis of indeterminate potential (CHIP) was evaluated on Cardiovascular traits and all-cause mortality (p=< 0.05).
Synapse has enriched 10 related papers. Consider them for comparative context: